Home › Funds › First Eagle Investment Management › PCRX
First Eagle Investment Management position in PCRX
PACIRA BIOSCIENCES INC · Health Care
Latest position (Q4 2023)103.08K sh
Reported value held$3.48M
Portfolio Weight0.01%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 24.83K | $1.49M | New |
| Q1 2022 | 47.72K | $3.64M | Add |
| Q2 2022 | 69.83K | $4.07M | Add |
| Q3 2022 | 78.53K | $4.18M | Add |
| Q4 2022 | 83.01K | $3.21M | Add |
| Q1 2023 | 176.43K | $7.20M | Add |
| Q2 2023 | 244.27K | $9.79M | Add |
| Q3 2023 | 207.63K | $6.37M | Reduce |
| Q4 2023 | 103.08K | $3.48M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCRX
- Vanguard Group 4.81M sh · $124.56M · Q4 2025
- D. E. Shaw & Co 1.95M sh · $49.48M · Q2 2026
- Renaissance Technologies 1.73M sh · $43.99M · Q2 2026
- Goldman Sachs Group 1.53M sh · $38.74M · Q2 2026
- Geode Capital Management 1.16M sh · $29.40M · Q2 2026
- Morgan Stanley 1.14M sh · $29.04M · Q2 2026
- UBS Group AG 920.22K sh · $23.35M · Q2 2026
- Two Sigma Investments 724.60K sh · $18.38M · Q2 2026
- Charles Schwab Investment Management 690.79K sh · $17.53M · Q2 2026
- Wellington Management Group 563.46K sh · $14.29M · Q2 2026
- Northern Trust Corp 526.78K sh · $13.36M · Q2 2026
- BNY Mellon 296.88K sh · $7.53M · Q2 2026